BenevolentAI Company Contacts

BenevevolentAI is a global pioneer and leader in AI-augmented drug discovery. We serve patients by leveraging our proprietary and validated Benevolent Platform that integrates AI and science to uncover new biology, predict novel targets and develop first-in-class or best-in-class drugs... Read More

Contacts

Country

United Kingdom

City

London

Headquarters

London, Greater London

Profile

Founded

2013

Industry

Biotechnology Research

Size

201 - 500

Specialties

Artificial Intelligence, Drug Development, Scientific Innovation, Machine Learning, Deep Learning, Big Data, Pharmaceutical, BioPharma, Drug Discovery

Funding

Total Rounds

Last Round

Mon Sep 16 2019

Last Round Series

Private equity

Last Round Raised

$ 90,000,000

BenevolentAI Company Contacts

BenevolentAI Add to my CRM

BenevolentAI